The human proto-oncogene RAS, which contains three sub-categories (HRAS, KRAS, and NRAS), is one of the most frequently mutated genes in cancers, with gain-of-function mutations occurring in approximately 30% of human malignancies [9]. This evidence concerns the gene KRAS and cancer.